eplex Search Results


90
GenMark Diagnostics eplex bcid
Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
Eplex Bcid, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/pmc08370220-119-3-2?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex bcid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioFire Defense eplex rp
Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
Eplex Rp, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/10__1128_slash_jcm__01658___17-109-4-11?v=BioFire+Defense
Average 90 stars, based on 1 article reviews
eplex rp - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex system
Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
Eplex System, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/pm39119904-23-1-0?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex blood panel
Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
Eplex Blood Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/pmc06447436-311-4-1?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex blood panel - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics dx eplex blood culture identification gramnegative panel
Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
Dx Eplex Blood Culture Identification Gramnegative Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/ppr0806659-277-27-26?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
dx eplex blood culture identification gramnegative panel - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex sarscov-2 test
Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
Eplex Sarscov 2 Test, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/10__1039_slash_D1AY00947H-168-4-9?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex sarscov-2 test - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex respiratory viral panel
Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
Eplex Respiratory Viral Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/pmc07383539-135-14-13?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex respiratory viral panel - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex ® bcid-gn
Select genotypic tests that are approved for rapid detection of resistance markers in positive blood cultures.
Eplex ® Bcid Gn, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/pmc07987685-11-0-3?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex ® bcid-gn - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex bcid panel-fp
Select genotypic tests that are approved for rapid detection of resistance markers in positive blood cultures.
Eplex Bcid Panel Fp, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/pmc07916227-130-1-4?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex bcid panel-fp - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex np
Select genotypic tests that are approved for rapid detection of resistance markers in positive blood cultures.
Eplex Np, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/pm36368779-40-9-22?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex np - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics genmark eplex
Select genotypic tests that are approved for rapid detection of resistance markers in positive blood cultures.
Genmark Eplex, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/10__1097_slash_cce__0000000000000154-75-15-15?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
genmark eplex - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex testing
Summary of <t> ePlex </t> results by site (N = 999)
Eplex Testing, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex/pmc09178061-172-3-3?v=GenMark+Diagnostics
Average 90 stars, based on 1 article reviews
eplex testing - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

doi: 10.1128/AAC.00441-21

Figure Lengend Snippet: Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

Article Snippet: Although the GenMark ePlex BCID demonstrated statistically higher mean DOOR-MAT scores than Verigene BC, both the immediate impact on an individual patient’s clinical outcome and the long-term impact on antimicrobial resistance is unknown.

Techniques:

Comparison of RDT platforms

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

doi: 10.1128/AAC.00441-21

Figure Lengend Snippet: Comparison of RDT platforms

Article Snippet: Although the GenMark ePlex BCID demonstrated statistically higher mean DOOR-MAT scores than Verigene BC, both the immediate impact on an individual patient’s clinical outcome and the long-term impact on antimicrobial resistance is unknown.

Techniques:

Select genotypic tests that are approved for rapid detection of resistance markers in positive blood cultures.

Journal: Frontiers in Medicine

Article Title: Rapid Antimicrobial Susceptibility Testing Methods for Blood Cultures and Their Clinical Impact

doi: 10.3389/fmed.2021.635831

Figure Lengend Snippet: Select genotypic tests that are approved for rapid detection of resistance markers in positive blood cultures.

Article Snippet: ePlex ® BCID-GN (GenMark) , 21 Gram-negative targets “pan” Gram-positive target “pan” Candida target , Carbapenemases bla IMP bla KPC bla OXA −48/ OXA −23 bla NDM bla VIM ESBL bla CTX − M , ( ) .

Techniques: Bla VIM Assay, Luminex

Summary of  ePlex  results by site (N = 999)

Journal: Influenza and Other Respiratory Viruses

Article Title: Viral co‐infections are associated with increased rates of hospitalization in those with influenza

doi: 10.1111/irv.12967

Figure Lengend Snippet: Summary of ePlex results by site (N = 999)

Article Snippet: Further characterization by Genmark ePlex testing of influenza subtypes and presence of viral co‐infections for the 999 specimens available for detailed characterization is described in Table .

Techniques: Virus

Patient characteristics by type of  influenza  co‐infection as determined by  ePlex  (N = 999)

Journal: Influenza and Other Respiratory Viruses

Article Title: Viral co‐infections are associated with increased rates of hospitalization in those with influenza

doi: 10.1111/irv.12967

Figure Lengend Snippet: Patient characteristics by type of influenza co‐infection as determined by ePlex (N = 999)

Article Snippet: Further characterization by Genmark ePlex testing of influenza subtypes and presence of viral co‐infections for the 999 specimens available for detailed characterization is described in Table .

Techniques: Virus